🎯 check EPZ-6438 (Tazemetostat) product page
EPZ-6438 (Tazemetostat) is a selective EZH2 inhibitor. It acts by blocking EZH2 activity, thereby reducing H3K27me3-mediated epigenetic silencing and disrupting key signaling pathways, which ultimately inhibits cancer cell proliferation and viability.